Giuseppe Roberto D'Agostino Selected Research

Neoplasm Metastasis (Metastasis)

1/2019	Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.
3/2015	Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
2/2010	Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Roberto D'Agostino Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 02/2010
6	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 11/2012
3	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2010
3	Carcinoma (Carcinomatosis) 09/2016 - 02/2010
2	Pain (Aches) 07/2018 - 02/2011
2	Residual Neoplasm 09/2016 - 03/2010
2	Breast Neoplasms (Breast Cancer) 04/2016 - 02/2010
2	Glioma (Gliomas) 10/2010 - 03/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2018
1	Neurologic Manifestations (Neurological Manifestations) 07/2018
1	Spinal Cord Compression 07/2018
1	Lymphatic Metastasis 10/2017
1	Inflammation (Inflammations) 09/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2016
1	Sarcoma (Soft Tissue Sarcoma) 03/2015
1	Stomach Neoplasms (Stomach Cancer) 01/2015
1	Cholangiocarcinoma 04/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2013
1	Adenocarcinoma 02/2013
1	Atrophy 11/2012
1	Glioblastoma (Glioblastoma Multiforme) 01/2012
1	Fibrosarcoma 11/2011
1	Plasma Cell Neoplasms 02/2011
1	Merkel Cell Carcinoma 05/2010
1	Erythema 05/2010
1	Seizures (Absence Seizure) 03/2010
1	Disease Progression 03/2010
1	Lung Neoplasms (Lung Cancer) 02/2010

Drug/Important Bio-Agent (IBA)

2	Temozolomide (Temodar)FDA LinkGeneric 10/2010 - 03/2010
1	AndrogensIBA 01/2020
1	Gemcitabine FDA Link 02/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2012
1	Hormones (Hormone)IBA 11/2012
1	Pharmaceutical PreparationsIBA 02/2011
1	Imiquimod (Aldara)FDA LinkGeneric 05/2010
1	Immunologic Factors (Immunomodulators)IBA 05/2010

Therapy/Procedure

21	Radiotherapy 01/2022 - 03/2010
3	Therapeutics 04/2016 - 03/2010
3	Drug Therapy (Chemotherapy) 04/2016 - 02/2010
2	Conformal Radiotherapy 10/2010 - 03/2010
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2019
1	Re-Irradiation 01/2019
1	Aftercare (After-Treatment) 07/2018
1	Curettage 07/2018
1	Decompression 07/2018
1	Chemoradiotherapy 09/2016
1	Neoadjuvant Therapy 09/2016
1	Adjuvant Chemoradiotherapy 01/2015
1	Brachytherapy 04/2014
1	Adjuvant Radiotherapy 11/2011
1	Adjuvant Chemotherapy 03/2010